Lyudmila Bazhenova is an Oncology physician affiliated with University of San Diego. OpenAlex indexes 565 publications with 18,721 citations (h-index 54); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
San Diego, CA 921039000
Telephone
858-822-6100Registry record last updated 23 Apr 2018.
Clinical trials
- Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
Sponsor: Lyudmila Bazhenova, M.D.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year202511 payments$10,966openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20254 payments$10,530openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20255 payments$10,390openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
64.8%Kinase inhibitor64.8%Tagrisso85%Lorbrena8%Tabrecta7%Part D<11 patientsMetabolism & gastrointestinal
15.6%Serotonin-3 Receptor Antagonist12%Ondansetron Hcl50%Ondansetron Odt50%Part D<11 patientsCorticosteroid3.7%Prednisone100%Part D<11 patientsNervous system
8.3%Phenothiazine8.3%Prochlorperazine Maleate100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Protocol Review and Monitoring Committee
University of California, San Diego
FY2024$139,926P30CA023100 - Ading color to cancer, adenovirus and flow cytometry to identify and capture CTCs
Nanocellect Biomedical, Inc.
FY2012$152,152R43CA163436
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3
Journal of Clinical Oncology
2024 - Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation
New England Journal of Medicine
2022 - Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Victor Nizet, MD
University of San Diego
Christopher Kane, MD
University of San Diego
Lawrence Marshall, MD
University of San Diego
Etienne Vasconcellosde Macedo, MD
University of San Diego
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”